DRUG · Mapped RxNorm record
bevacizumab
Normalized identity: bevacizumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
NCT00370721
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedIntravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
bevacizumabDRUG · verified · RxNorm: bevacizumab
Sponsors & collaborators
Shahid Beheshti University of Medical Scienceslead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00370721 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.